• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

更正：马哈辛等人。泰国新冠疫苗接种后的心肌炎和心包炎。2023年，，749。

Correction: Mahasing et al. Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand. 2023, , 749.

作者信息

Mahasing Chayanit, Doungngern Pawinee, Jaipong Rittichai, Nonmuti Poonyaporn, Chimmanee Jirapa, Wongsawat Jurai, Boonyasirinant Thananya, Wanlapakorn Chaisiri, Leelapatana Pattranee, Yingchoncharoen Teerapat, Ngarmukos Tachapong, Chokephaibulkit Kulkanya, Srimahachota Suphot

机构信息

Division of Epidemiology, Department of Disease Control, Ministry of Public Health, Building 10 Floor 3, 88/21 Tiwanon Rd., Nonthaburi 11000, Thailand.

Bamrasnaradura Infectious Diseases Institute, Nonthaburi 11000, Thailand.

出版信息

Vaccines (Basel). 2023 Oct 12;11(10):1589. doi: 10.3390/vaccines11101589.

DOI:10.3390/vaccines11101589
PMID:37897030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10610549/
Abstract

The authors wish to make the following corrections to this published paper [...].

摘要

作者希望对已发表的该论文做出如下更正

[...]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa1/10610549/45be8ab278c7/vaccines-11-01589-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa1/10610549/45be8ab278c7/vaccines-11-01589-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa1/10610549/45be8ab278c7/vaccines-11-01589-g001.jpg

相似文献

1
Correction: Mahasing et al. Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand. 2023, , 749.更正：马哈辛等人。泰国新冠疫苗接种后的心肌炎和心包炎。2023年，，749。
Vaccines (Basel). 2023 Oct 12;11(10):1589. doi: 10.3390/vaccines11101589.
2
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand.泰国新冠疫苗接种后的心肌炎和心包炎
Vaccines (Basel). 2023 Mar 28;11(4):749. doi: 10.3390/vaccines11040749.
3
A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID-19 mRNA vaccination.大规模疫苗接种运动期间疫苗药物警戒的叙述性综述：关注 COVID-19 mRNA 疫苗接种后的心肌炎和心包炎。
Br J Clin Pharmacol. 2023 Mar;89(3):967-981. doi: 10.1111/bcp.15625. Epub 2022 Dec 26.
4
Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature.报告显示，接种 mRNA COVID-19 疫苗后可能引发心肌炎和心包炎：对来自英国、欧洲和美国的自发报告数据以及科学文献的系统评价。
BMJ Open. 2022 May 25;12(5):e059223. doi: 10.1136/bmjopen-2021-059223.
5
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.新型冠状病毒肺炎（COVID-19）疫苗接种后心肌炎和心包炎的发生率、危险因素、自然史和假设发病机制：基于实时证据的综合分析和综述。
BMJ. 2022 Jul 13;378:e069445. doi: 10.1136/bmj-2021-069445.
6
Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system.与基础免疫相比，COVID-19 mRNA 疫苗加强针不会增加心肌炎和心包炎的风险：疫苗不良事件报告系统的新见解。
Front Immunol. 2022 Sep 12;13:938322. doi: 10.3389/fimmu.2022.938322. eCollection 2022.
7
Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.mRNA COVID-19 疫苗接种后的心肌炎和/或心包炎风险：BNT162b2 和 mRNA-1273 疫苗的加拿大头对头比较。
Vaccine. 2022 Jul 30;40(32):4663-4671. doi: 10.1016/j.vaccine.2022.05.048. Epub 2022 May 25.
8
Risks of Myocarditis and Pericarditis Following Vaccination with SARS-CoV-2 mRNA Vaccines in Japan: An Analysis of Spontaneous Reports of Suspected Adverse Events.日本接种 SARS-CoV-2 mRNA 疫苗后心肌炎和心包炎的风险：疑似不良事件自发报告分析。
Ther Innov Regul Sci. 2023 Mar;57(2):329-342. doi: 10.1007/s43441-022-00466-1. Epub 2022 Oct 30.
9
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.意大利 12 至 39 岁人群接种 COVID-19 mRNA 疫苗后的心肌炎和心包炎上市后主动监测：多数据库、自身对照病例系列研究。
PLoS Med. 2022 Jul 28;19(7):e1004056. doi: 10.1371/journal.pmed.1004056. eCollection 2022 Jul.
10
Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types.新冠病毒疫苗接种后的心肌炎和心包炎：年龄及疫苗类型方面的不平等现象
J Pers Med. 2021 Oct 28;11(11):1106. doi: 10.3390/jpm11111106.

本文引用的文献

1
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand.泰国新冠疫苗接种后的心肌炎和心包炎
Vaccines (Basel). 2023 Mar 28;11(4):749. doi: 10.3390/vaccines11040749.